Cartesian Therapeutics Inc. Cash Flow-to-Debt Ratio
Cartesian Therapeutics Inc. cash flow-to-debt ratio. Cartesian Therapeutics Inc. (RNAC) has a Cash Flow-to-Debt Ratio of -0.05x as of March 2026, meaning its operating cash flow of $-22.14 Million could theoretically repay 0% of its total liabilities ($436.51 Million) in one year. Check RNAC cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Cartesian Therapeutics Inc. (2014–2025)
Cash flow-to-debt ratio of Cartesian Therapeutics Inc. from 2014 to 2025. Historical debt coverage capacity for Cartesian Therapeutics Inc. across 12 annual periods. Check how aggressively does Cartesian Therapeutics Inc. reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Cartesian Therapeutics Inc. Cash Flow-to-Debt Ratio by Year (2014–2025)
Cartesian Therapeutics Inc. cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for Cartesian Therapeutics Inc.. For the full cash flow conversion analysis, see Cartesian Therapeutics Inc. cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.17x | $-73.94 Million | $422.65 Million | ▼ -226.5% |
| 2024 | -0.05x | $-23.67 Million | $441.82 Million | ▲ +21.9% |
| 2023 | -0.07x | $-51.16 Million | $745.23 Million | ▲ +84.4% |
| 2022 | -0.44x | $-31.63 Million | $72.06 Million | ▲ +0.1% |
| 2021 | -0.44x | $-60.38 Million | $137.36 Million | ▼ -331.2% |
| 2020 | 0.19x | $34.88 Million | $183.44 Million | ▲ +133.7% |
| 2019 | -0.56x | $-51.44 Million | $91.17 Million | ▲ +52.4% |
| 2018 | -1.19x | $-59.16 Million | $49.90 Million | ▼ -12.3% |
| 2017 | -1.06x | $-52.04 Million | $49.29 Million | ▼ -84.2% |
| 2016 | -0.57x | $-19.68 Million | $34.34 Million | ▼ -306.5% |
| 2015 | -0.14x | $-22.46 Million | $159.32 Million | ▼ -22.2% |
| 2014 | -0.12x | $-12.69 Million | $109.98 Million | — |